Payment overview · 2025
General Payments
$51.45
3 reported records · 3 companies
Healthcare provider profile · identity verified
Gary W Spangler, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · ALVIN, TX · NPI 1952395048
Verified facts
What the public records show
CMS Open Payments records show Gary W Spangler, M.D. received $51.45 in general payments during 2025 across 3 reported records.
Philips North America LLC accounted for 35.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Philips North America LLC | Unresolved — no canonical attribution shown | $18.45 | 35.9% | 1 | 2025 |
| Inspire Medical Systems, Inc. | Unresolved — no canonical attribution shown | $17.77 | 34.5% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $15.23 | 29.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $51.45 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| inCourage Airway Clearance Therapy Normalized: incourage airway clearance therapy |
Device | Philips North America LLC | $18.45 | 1 | 2025 |
Source payment records
|
|||||
| INSPIRE Normalized: inspire |
Device | Inspire Medical Systems, Inc. | $17.77 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $15.23 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 808 | 120 |
| Levothyroxine Sodium | Levothyroxine Sodium | 506 | 54 |
| Furosemide | Furosemide | 391 | 65 |
| Gabapentin | Gabapentin | 371 | 61 |
| Eliquis | Apixaban | 352 | 37 |
| Amlodipine Besylate | Amlodipine Besylate | 342 | 63 |
| Donepezil Hcl | Donepezil Hcl | 341 | 44 |
| Lisinopril | Lisinopril | 302 | 40 |
| Mirtazapine | Mirtazapine | 294 | 45 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 287 | 44 |
| Metoprolol Tartrate | Metoprolol Tartrate | 286 | 40 |
| Potassium Chloride | Potassium Chloride | 267 | 36 |
| Metformin Hcl | Metformin Hcl | 263 | 35 |
| Clopidogrel | Clopidogrel Bisulfate | 249 | 30 |
| Tamsulosin Hcl | Tamsulosin Hcl | 244 | 34 |
| Pantoprazole Sodium | Pantoprazole Sodium | 230 | 47 |
| Memantine Hcl | Memantine Hcl | 224 | 31 |
| Trazodone Hcl | Trazodone Hcl | 219 | 40 |
| Divalproex Sodium | Divalproex Sodium | 187 | 27 |
| Famotidine | Famotidine | 186 | 26 |
| Sertraline Hcl | Sertraline Hcl | 168 | 23 |
| Metoprolol Succinate | Metoprolol Succinate | 161 | 26 |
| Levetiracetam | Levetiracetam | 160 | 19 |
| Carvedilol | Carvedilol | 136 | 28 |
| Escitalopram Oxalate | Escitalopram Oxalate | 126 | 18 |
| Buspirone Hcl | Buspirone Hcl | 125 | 26 |
| Duloxetine Hcl | Duloxetine Hcl | 113 | 20 |
| Simvastatin | Simvastatin | 111 | 13 |
| Spironolactone | Spironolactone | 111 | 20 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 110 | 22 |
| Fluticasone Propionate | Fluticasone Propionate | 108 | 28 |
| Omeprazole | Omeprazole | 107 | 20 |
| Montelukast Sodium | Montelukast Sodium | 97 | suppressed |
| Losartan Potassium | Losartan Potassium | 96 | 19 |
| Myrbetriq | Mirabegron | 95 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 87 | 37 |
| Latanoprost | Latanoprost | 84 | 13 |
| Hydralazine Hcl | Hydralazine Hcl | 83 | 18 |
| Tradjenta | Linagliptin | 80 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 77 | suppressed |
| Allopurinol | Allopurinol | 76 | suppressed |
| Baclofen | Baclofen | 74 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 74 | 26 |
| Finasteride | Finasteride | 72 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 69 | 16 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 66 | 11 |
| Ondansetron Hcl | Ondansetron Hcl | 63 | 31 |
| Jardiance | Empagliflozin | 62 | suppressed |
| Lactulose | Lactulose | 61 | 22 |
| Brimonidine Tartrate | Brimonidine Tartrate | 57 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 57 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 56 | 16 |
| Diclofenac Sodium | Diclofenac Sodium | 55 | 19 |
| Humalog Kwikpen U-100 | Insulin Lispro | 51 | 11 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 50 | 12 |
| Entresto | Sacubitril/Valsartan | 50 | suppressed |
| Atenolol | Atenolol | 47 | suppressed |
| Bumetanide | Bumetanide | 45 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 45 | 13 |
| Sucralfate | Sucralfate | 45 | suppressed |
| Meloxicam | Meloxicam | 44 | suppressed |
| Ibuprofen | Ibuprofen | 42 | suppressed |
| Glimepiride | Glimepiride | 41 | suppressed |
| Glipizide | Glipizide | 41 | suppressed |
| Hydrocortisone | Hydrocortisone | 40 | 14 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 40 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 40 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 39 | 18 |
| Pregabalin | Pregabalin | 39 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 38 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 38 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 36 | 24 |
| Alendronate Sodium | Alendronate Sodium | 35 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 35 | 11 |
| Nifedipine Er | Nifedipine | 35 | suppressed |
| Nystatin | Nystatin | 35 | 15 |
| Humulin R | Insulin Regular, Human | 34 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 34 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 34 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 33 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 33 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 33 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 32 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 32 | suppressed |
| Prednisone | Prednisone | 32 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 31 | suppressed |
| Folic Acid | Folic Acid | 31 | suppressed |
| Risperidone | Risperidone | 31 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 31 | 17 |
| Enalapril Maleate | Enalapril Maleate | 30 | suppressed |
| Enulose | Lactulose | 30 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 30 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 30 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 30 | suppressed |
| Xarelto | Rivaroxaban | 30 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 29 | suppressed |
| Olanzapine | Olanzapine | 29 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 28 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 27 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 26 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 26 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 26 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 26 | 20 |
| Gemtesa | Vibegron | 25 | suppressed |
| Januvia | Sitagliptin Phosphate | 25 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 25 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 24 | 16 |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 24 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 23 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 23 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 23 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 22 | suppressed |
| Carbamazepine Er | Carbamazepine | 22 | suppressed |
| Digoxin | Digoxin | 22 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 22 | suppressed |
| Brilinta | Ticagrelor | 21 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 19 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 19 | 18 |
| Azathioprine | Azathioprine | 19 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 19 | suppressed |
| Lorazepam | Lorazepam | 19 | suppressed |
| Methocarbamol | Methocarbamol | 19 | suppressed |
| Travoprost | Travoprost | 19 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 18 | 11 |
| Lidocaine | Lidocaine | 18 | suppressed |
| Pentoxifylline | Pentoxifylline | 18 | suppressed |
| Amantadine | Amantadine Hcl | 17 | suppressed |
| Amoxicillin | Amoxicillin | 17 | 14 |
| Brinzolamide | Brinzolamide | 17 | suppressed |
| Klayesta | Nystatin | 17 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 17 | 13 |
| Nystop | Nystatin | 17 | 11 |
| Risperdal Consta | Risperidone Microspheres | 17 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 17 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 16 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 16 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Trulicity | Dulaglutide | 16 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 15 | suppressed |
| Nyamyc | Nystatin | 15 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 15 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 15 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 14 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 14 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 14 | suppressed |
| Fluconazole | Fluconazole | 14 | suppressed |
| Ketoconazole | Ketoconazole | 14 | suppressed |
| Levofloxacin | Levofloxacin | 14 | suppressed |
| Clindamycin Phosphate | Clindamycin Phosphate | 13 | suppressed |
| Lovastatin | Lovastatin | 13 | suppressed |
| Metolazone | Metolazone | 13 | suppressed |
| Ondansetron Odt | Ondansetron | 13 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 12 | suppressed |
| Guanfacine Hcl | Guanfacine Hcl | 12 | suppressed |
| Linzess | Linaclotide | 12 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 12 | suppressed |
| Nitroglycerin | Nitroglycerin | 12 | 12 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 12 | suppressed |
| Vascepa | Icosapent Ethyl | 12 | suppressed |
| Acetazolamide | Acetazolamide | 11 | suppressed |
| Aripiprazole | Aripiprazole | 11 | suppressed |
| Cefdinir | Cefdinir | 11 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 11 | suppressed |
| Clonidine | Clonidine | 11 | suppressed |
| Humalog | Insulin Lispro | 11 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 11 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 11 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 11 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 11 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $51.45 · 3 records | Philips North America LLC | Cologuard Collection Kit, INSPIRE, inCourage Airway Clearance Therapy | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error